Mutations in porin LamB contribute to ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae

被引:26
|
作者
Guo, Yingyi [1 ]
Liu, Ningjing [1 ]
Lin, Zhiwei [2 ]
Ba, Xiaoliang [3 ]
Zhuo, Chuyue [1 ]
Li, Feifeng [1 ]
Wang, Jiong [1 ]
Li, Yitan [2 ]
Yao, Likang [1 ]
Liu, Baomo [1 ]
Xiao, Shunian [1 ]
Jiang, Ying [1 ]
Zhuo, Chao [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Guangzhou, Peoples R China
[2] Peoples Hosp Yangjiang, Lab Resp Dis, Yangjiang, Guangdong, Peoples R China
[3] Univ Cambridge, Dept Vet Med, Cambridge, England
基金
中国国家自然科学基金;
关键词
Ceftazidime-avibactam; KPC; LamB; PBP3; expression level of bla (KPC); IN-VITRO ACTIVITY; ESCHERICHIA-COLI; MOLECULAR EPIDEMIOLOGY; ENTEROBACTERIACEAE; ACID;
D O I
10.1080/22221751.2021.1984182
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ceftazidime-avibactam (CAZ-AVI) shows promising activity against carbapenem-resistant Klebsiella pneumoniae (CRKP), however, CAZ-AVI resistance have emerged recently. Mutations in KPCs, porins OmpK35 and/or OmpK36, and PBPs are known to contribute to the resistance to CAZ-AVI in CRKP. To identify novel CAZ-AVI resistance mechanism, we generated 10 CAZ-AVI-resistant strains from 14 CAZ-AVI susceptible KPC-producing K. pneumoniae (KPC-Kp) strains through in vitro multipassage resistance selection using low concentrations of CAZ-AVI. Comparative genomic analysis for the original and derived mutants identified CAZ-AVI resistance-associated mutations in KPCs, PBP3 (encoded by ftsI), and LamB, an outer membrane maltoporin. CAZ-AVI susceptible KPC-Kp strains became resistant when complemented with mutated bla (KPC) genes. Complementation experiments also showed that a plasmid borne copy of wild-type lamB or ftsI gene reduced the MIC value of CAZ-AVI in the induced resistant strains. In addition, bla (KPC) expression level increased in four of the six CAZ-AVI-resistant strains without KPC mutations, indicating a probable association between increased bla (KPC) expression and increased resistance in these strains. In conclusion, we here identified a novel mechanism of CAZ-AVI resistance associated with mutations in porin LamB in KPC-Kp.
引用
收藏
页码:2042 / 2051
页数:10
相关论文
共 50 条
  • [1] Ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae accompanied hypermucoviscosity acquisition
    Guo, Yingyi
    Wang, Jiong
    Yao, Likang
    Wang, Yijing
    Zhang, Yan
    Zhuo, Chuyue
    Yang, Xu
    Li, Feifeng
    Li, Jiahui
    Liu, Baomo
    He, Nanhao
    Chen, Jiakang
    Xiao, Shunian
    Lin, Zhiwei
    Zhuo, Chao
    BMC MICROBIOLOGY, 2024, 24 (01):
  • [2] Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3
    Humphries, Romney M.
    Hemarajata, Peera
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
  • [3] Ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in KPC-producing Klebsiella pneumoniae infections: A case series
    van Asten, S. A., V
    Boattini, M.
    Kraakman, M. E. M.
    Bianco, G.
    Iannaccone, M.
    Costa, C.
    Cavallo, R.
    Bernards, A. T.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (05) : 778 - 780
  • [4] In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
    Huang, Yanqin
    Wu, Tiffany
    Perez, Omar
    Rana, Amisha P.
    Chen, Liang
    Kreiswirth, Barry N.
    Satlin, Michael J.
    Bulman, Zackery P.
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [5] Changes in KPC-producing Klebsiella pneumoniae susceptibility from the pre- to ceftazidime-avibactam era
    Boattini, Matteo
    Bianco, Gabriele
    Comini, Sara
    Iannaccone, Marco
    Casale, Roberto
    Charrier, Lorena
    Cavallo, Rossana
    Costa, Cristina
    INFECTIOUS DISEASES, 2022, 54 (04) : 311 - 313
  • [6] Pharmacokinetics of Ceftazidime-Avibactam in Two Patients With KPC-Producing Klebsiella pneumoniae Bacteremia and Renal Impairment
    Veillette, John J.
    Truong, James
    Forland, Steven C.
    PHARMACOTHERAPY, 2016, 36 (11): : E172 - E177
  • [7] Ceftazidime/avibactam resistance is associated with different mechanisms in KPC-producing Klebsiella pneumoniae strains
    Cavallini, Sara
    Unali, Ilaria
    Bertoncelli, Anna
    Cecchetto, Riccardo
    Mazzariol, Annarita
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2021, 68 (04) : 235 - 239
  • [8] High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae
    Shen, Zhen
    Ding, Baixing
    Ye, Meiping
    Wang, Peng
    Bi, Yingmin
    Wu, Shi
    Xu, Xiaogang
    Guo, Qinglan
    Wang, Minggui
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (07) : 1930 - 1936
  • [10] The prevalence and mechanisms of heteroresistance to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae
    Zhang, Xiaotuan
    Zeng, Weiliang
    Kong, Jingchun
    Huang, Zeyu
    Shu, Hongyun
    Tang, Miran
    Qian, Changrui
    Xu, Chunquan
    Zhou, Tieli
    Ye, Jianzhong
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 1865 - 1876